Pierre-Grégoire Guinot1,2, Osama Abou-Arab3, Mathieu Guilbart3, Stéphane Bar3, Elie Zogheib3, Mona Daher3, Patricia Besserve3, Joseph Nader4,5, Thierry Caus4,5, Said Kamel4, Hervé Dupont3,4, Emmanuel Lorne3,4. 1. Department of Anaesthesiology and Critical Care Medicine, Amiens University Hospital, Place Victor Pauchet, 80054, Amiens, France. guinotpierregregoire@gmail.com. 2. INSERM U1088, Jules Verne University of Picardy, 80054, Amiens, France. guinotpierregregoire@gmail.com. 3. Department of Anaesthesiology and Critical Care Medicine, Amiens University Hospital, Place Victor Pauchet, 80054, Amiens, France. 4. INSERM U1088, Jules Verne University of Picardy, 80054, Amiens, France. 5. Department of Cardiac Surgery, Amiens University Hospital, 80054, Amiens, France.
Abstract
PURPOSE: To evaluate the ability of an algorithm based on dynamic arterial elastance to decrease the duration of norepinephrine treatment. METHODS: We performed a prospective, open-label, randomized study in patients requiring norepinephrine for vasoplegic syndrome after cardiac surgery with cardiopulmonary bypass. Patients were randomized to an algorithm-based intervention group or a control group. The primary outcome was the duration of norepinephrine treatment. The secondary outcomes included the total dose of norepinephrine, the length of stay (LOS) in the ICU, central venous oxygen saturation, arterial lactate levels, arrhythmia and diuresis. RESULTS:Of 130 included patients, 118 were analysed on an intention-to-treat basis (intervention group: n = 59; control group: n = 59). On inclusion, the intervention and control groups did not differ significantly in terms of demographic characteristics, surgical data or the prior duration of norepinephrine treatment [5 h (4-10) vs. 5 h (5-7), respectively; P = 0.543]. The cumulative duration of norepinephrine treatment after inclusion was shorter in the intervention group than in the control group [17 h (13-26)] vs. 39 h (19-58), respectively; (P < 0.001). The cumulative dose of norepinephrine and the LOS in the ICU were also lower in the intervention group (P < 0.05). There were no intergroup differences for other outcomes (the sepsis-related organ failure score, central venous oxygen saturation, arrhythmia, and arterial lactate levels). CONCLUSION: A haemodynamic algorithm based on dynamic arterial elastance was associated with a shorter duration of norepinephrine treatment and a shorter LOS in the ICU. Use of the algorithm did not alter perfusion parameters or increase the volume of fluid infused. ClinicalTrials.gov Identifier: NCT02479529.
RCT Entities:
PURPOSE: To evaluate the ability of an algorithm based on dynamic arterial elastance to decrease the duration of norepinephrine treatment. METHODS: We performed a prospective, open-label, randomized study in patients requiring norepinephrine for vasoplegic syndrome after cardiac surgery with cardiopulmonary bypass. Patients were randomized to an algorithm-based intervention group or a control group. The primary outcome was the duration of norepinephrine treatment. The secondary outcomes included the total dose of norepinephrine, the length of stay (LOS) in the ICU, central venous oxygen saturation, arterial lactate levels, arrhythmia and diuresis. RESULTS: Of 130 included patients, 118 were analysed on an intention-to-treat basis (intervention group: n = 59; control group: n = 59). On inclusion, the intervention and control groups did not differ significantly in terms of demographic characteristics, surgical data or the prior duration of norepinephrine treatment [5 h (4-10) vs. 5 h (5-7), respectively; P = 0.543]. The cumulative duration of norepinephrine treatment after inclusion was shorter in the intervention group than in the control group [17 h (13-26)] vs. 39 h (19-58), respectively; (P < 0.001). The cumulative dose of norepinephrine and the LOS in the ICU were also lower in the intervention group (P < 0.05). There were no intergroup differences for other outcomes (the sepsis-related organ failure score, central venous oxygen saturation, arrhythmia, and arterial lactate levels). CONCLUSION: A haemodynamic algorithm based on dynamic arterial elastance was associated with a shorter duration of norepinephrine treatment and a shorter LOS in the ICU. Use of the algorithm did not alter perfusion parameters or increase the volume of fluid infused. ClinicalTrials.gov Identifier: NCT02479529.
Authors: Maurizio Cecconi; M Ignacio Monge García; Manuel Gracia Romero; Johannes Mellinghoff; Francesca Caliandro; Robert Michael Grounds; Andrew Rhodes Journal: Anesth Analg Date: 2015-01 Impact factor: 5.108
Authors: Eduardo A Osawa; Andrew Rhodes; Giovanni Landoni; Filomena R B G Galas; Julia T Fukushima; Clarice H L Park; Juliano P Almeida; Rosana E Nakamura; Tania M V Strabelli; Brunna Pileggi; Alcino C Leme; Evgeny Fominskiy; Yasser Sakr; Marta Lima; Rafael A Franco; Raquel P C Chan; Marilde A Piccioni; Priscilla Mendes; Suéllen R Menezes; Tatiana Bruno; Fabio A Gaiotto; Luiz A Lisboa; Luiz A O Dallan; Alexandre C Hueb; Pablo M Pomerantzeff; Roberto Kalil Filho; Fabio B Jatene; Jose Otavio Costa Auler Junior; Ludhmila A Hajjar Journal: Crit Care Med Date: 2016-04 Impact factor: 7.598
Authors: R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno Journal: Intensive Care Med Date: 2013-01-30 Impact factor: 17.440
Authors: Mehdi Merouani; Bruno Guignard; François Vincent; Stephen W Borron; Philippe Karoubi; Jean-Philippe Fosse; Yves Cohen; Christophe Clec'h; Eric Vicaut; Carole Marbeuf-Gueye; Frederic Lapostolle; Frederic Adnet Journal: Crit Care Date: 2008-12-09 Impact factor: 9.097
Authors: M H Møller; C Claudius; E Junttila; M Haney; A Oscarsson-Tibblin; A Haavind; A Perner Journal: Acta Anaesthesiol Scand Date: 2016-08-31 Impact factor: 2.105
Authors: Hugues de Courson; Philippe Boyer; Romain Grobost; Romain Lanchon; Musa Sesay; Karine Nouette-Gaulain; Emmanuel Futier; Matthieu Biais Journal: Ann Intensive Care Date: 2019-10-11 Impact factor: 6.925
Authors: Manuel Ignacio Monge García; Zhongping Jian; Feras Hatib; Jos J Settels; Maurizio Cecconi; Michael R Pinsky Journal: Front Physiol Date: 2020-04-06 Impact factor: 4.566